Login / Signup

Exploring the Potential of Exosomal Biomarkers in Mild Traumatic Brain Injury and Post-Concussion Syndrome: A Systematic Review.

Ioannis A MavroudisSidra JabeenIoana Miruna BalmusAlin CiobicaVasile BurluiLaura RomilaAlin Iordache
Published in: Journal of personalized medicine (2023)
Salivary exosomal biomarkers have the potential to serve as non-invasive and easily accessible diagnostic and prognostic tools for mTBI and PCS. Further studies are needed to validate these biomarkers and develop standardized protocols for their use in clinical settings. Salivary exosomal biomarkers can improve the diagnosis, monitoring, and treatment of mTBI and PCS, leading to improved patient outcomes.
Keyphrases
  • mild traumatic brain injury
  • risk assessment
  • human health
  • smoking cessation
  • replacement therapy